Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma

NCT03465891 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual and lack of funding.

Conditions

Lymphoma

Interventions

DRUG: atezolizumab
RADIATION: Low- Dose, Local Radiotherapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]